India's Commonwealth Championship silver medallist weightlifter Seema has been slapped with a four-year suspension for a doping violation.
In a statement, the National Anti-Doping Agency (NADA) said Seema's dope sample was collected this year during the 34th Women National Weightlifting Championship in Vishakhapatnam.
"Presence of prohibited substances were found in her system during an ongoing Championship to enhance her performance which amounted to a clear cut case of cheating and outright violation of National Anti-Doping rules," said a statement.
"The analysis report of her sample returned an Adverse Analytical Finding (AAF) for presence of a prohibited substance namely Hydroxy-4-methoxy Temoxifen (Metabolite of Tamoxifen), Selective Estrogen Receptor Modular (SERM) Metenolone, Anabolic Steroid Ostarine ( Enobosram), Selective Androgen Receptor Modular (SARM)."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
